Recombinant IL23A (Guselkumab Biosimilar) anticorps
Research Grade
Reactivité: Humain
ELISA
Hôte: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Antigène
- IL23A (Guselkumab Biosimilar)
- Type d'anticorp
- Recombinant Antibody
- Reactivité
- Humain
-
Hôte
-
Mammalian Cells
- Expression System
- Mammalian cells
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp IL23A (Guselkumab Biosimilar) est non-conjugé
- Application
- ELISA
- Fonction
- Guselkumab Biosimilar - Anti-IL23A mAb
- Attributs du produit
- Antibody Type: IgG1-lambda
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Classe de qualité
- Research Grade
- Isotype
- IgG1 lambda
-
anti-IL23A (Guselkumab Biosimilar) (Glu239Asp-Mutant), (Met241Leu-Mutant) antibody
Research Grade Reactivité: Humain ELISA Hôte: Humanized Monoclonal unconjugated
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS pH 7.5
- Stock
- -80 °C
- Stockage commentaire
- store at -80°C
-
- Antigène
- IL23A (Guselkumab Biosimilar)
- Classe de substances
- Biosimilar
- Sujet
-
CNTO-1959
Guselkumab is a human IgG1 lambda monoclonal antibody that targets interleukin-23. IL-23 is an inflammatory cytokine that is reponsible for the activation of the CD4+ T-helper (Th17) cell pathway in the inflammatory cascade that induces psoriatic plaque formation. Guselkumab has been used to treat psoriasis. - Numéro CAS
- 1350289-85-8
-
Vous êtes ici:
